Oxidant-induced damage to the intima of pulmonary and systemic vessels is thought to be an important mechanism of injury in a variety of syndromes of vascular damage. Hydrogen peroxide (H2O2) is an active oxygen metabolite that may induce intimal injury by cytolytic attack or by inducing biochemical and functional alterations in the endothelial cells (EC); however, mechanisms involved in noncytolytic perturbation of EC are largely unknown. We found that H2O2 stimulated the synthesis of platelet-activating factor (PAF) by primary cultures of bovine pulmonary artery endothelium (BPAEC) and by human umbilical vein endothelium (HUVEC). In each cell type the incorporation of [3H]acetate into [3Hacetyl]PAF was concentration-and time-dependent and was temporally dissociated from severe plasma membrane disruption and cytolytic cell injury; the newly synthesized PAF remained associated with the EC. H2O2 caused permeabilization of EC to 45Ca2+ and an increase in intracellular Ca2+, suggesting that a transmembrane Ca2+ flux is the signal that initiates PAF synthesis. H2O2 also induced the endothelial cell-dependent adhesion of neutrophils to HUVEC monolayers. This response was rapid, with an onset within minutes and a subsequent time course that paralleled the time course of PAF accumulation, and was dependent on extracellular Ca2+ but not on de novo protein synthesis. These studies demonstrate that H2O2 can induce two rapid activation responses of endothelium, PAF synthesis and EC-dependent neutrophil […]
Introduction
It is currently thought that oxidant-induced injury to endothelium is an important mechanism of vascular damage (1) (2) (3) . Injury to the vascular intima caused by oxidants can result from endogenously produced active O2 metabolites that are generated in response to high partial pressures of 02, ionizing radiation, or drugs, or by oxidant species released by other cells, such as leukocytes (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Hydrogen peroxide (H202), in particular, may be a key molecular species in such injury: it has been implicated in in vitro endothelial cell (EC)' injury (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) , increased vascular permeability in ex vivo and wholeanimal lung models (14) (15) (16) (17) , and in postischemic tissue reperfusion injury (18) . One mechanism of this injury is lysis of EC (4-1 1). However, it is also possible that H202 causes changes in the endothelium that initiate or amplify vascular responses in the absence of, or before, cytolytic injury, such as the synthesis of biologically active molecules.
EC synthesize a number of substances that may be involved in local mechanisms of coagulation and inflammation ( 19) . One of these is platelet-activating factor (1 -0-alkyl-2-acetyl-sn-glycero-3-phosphocholine; PAF) (20, 21) , which is produced when EC are stimulated by agonists that interact with specific plasma membrane receptors (22, 23) . PAF is a phospholipid autacoid with known vasoactive and proinflammatory effects (24) (25) (26) . Although it may be important in local vascular homeostasis (20, 26) , it has also been implicated as a mediator of vascular injury (20, (27) (28) (29) (30) (31) (32) . For example, it causes pulmonary hypertension and lung edema under some conditions (29) (30) (31) (32) . Since H202 also causes these vascular responses (14) (15) (16) (17) , we examined the possibility that PAF may be produced by endothelium that has been perturbed by H202. Our findings demonstrate that H202 induces the synthesis and accumulation of PAF by bovine pulmonary artery endothelial cells (BPAEC) and human umbilical vein endothelial cells (HUVEC) in a concentration-, time-, and calcium-dependent manner that is temporally dissociated from lytic cell injury. In addition, H202 stimulates endothelial cell-dependent neutrophil adherence that is tightly coupled with PAF synthesis, suggesting that PAF may mediate the cell-cell interaction.
Methods
Materials PAF (> 99% pure) was purchased from Avanti Polar Lipids, Inc. (Birmingham, AL). Calcium ionophore A23 187 (IoA), cycloheximide, actinomycin D, bradykinin, catalase, and superoxide dismutase (SOD) were (Fairlawn, NJ) . Purified human thrombin was a gift from Dr. John Fenton (Albany, NY). Polyclonal rabbit antisera to human von Willebrand factor (vWF) and human fibronectin (Fn) were from Calbiochem-Behring Corp. (San Diego, CA) and Cappell (Cooper Biomedical, Malvern, PA), respectively, and were shown to interact with vWFand Fn associated with EC by indirect immunofluorescent staining.
EC culture
Pulmonary artery. Cultures of tightly confluent bovine pulmonary artery EC were prepared utilizing methods described in detail elsewhere (33) .
Human umbilical vein. Primary cultures of tightly confluent HUVEC were prepared as previously described (20, 22) .
EC cultured by these methods were characterized using morphologic (phase-contrast microscopy), immunologic (staining for vWF), and functional (uptake of acetylated LDL, angiotensin-converting enzyme activity, PGI2 synthesis) criteria as previously described (20, 22, 33) . Only primary cultures were used for these experiments.
Assay ofPAF production
Production of PAF in BPAEC was measured by incorporation of [3H]acetate into PAF by a modification of the method of Mueller et al. (34) as described in detail elsewhere (22, 33) . This has been shown to be an accurate method of measuring PAF accumulation in a variety of cell types (20, 22, (33) (34) (35) (36) and to correlate closely with quantitation by gas chromatography-mass spectroscopy (35) or by bioassay (20, 22, 36) . Briefly, the medium was removed from confluent EC monolayers and replaced with 1 ml of HBSS/ 10mM Hepes (pH 7.4), containing 25 jgCi of carrier-free [3H]acetate, and the appropriate concentration of H202 or control buffer. In some incubations catalase or SOD was included in the incubation mixture. The incubations were performed at 250C and were stopped at the indicated times by the addition of 0.5 ml of 50 mM acetic acid in methanol. After the addition of the acidified methanol, the cells were scraped from the surface of the culture dish. 50 gg of cold "carrier" PAF was added and the lipids were extracted by the method of Bligh and Dyer (37) . The sample was dried under N2, dissolved in a known volume ofchloroform/methanol (9:1), and 10% was removed and used to determine the total radioactivity present. The remaining lipids were then separated by thin layer chromatography on precoated plates of silica gel 60 in CHCl3/MeOH/glacial acetic acid/water (50:25:8:4) . The silica was scraped, in fractions corresponding to authentic standards, from the entire lane of a TLC plate, and the radioactivity in each fraction was determined by liquid scintillation spectrometry. Calculation of the radioactivity incorporated into [3H-acetyl]PAF was done as described (33) . Identification of the radiolabeled product as PAF in EC incubated in this fashion was established by determining its mobility in TLC and HPLC systems, its pattern of degradation by phospholipases Al and A2 and by a highly specific PAF acetylhydrolase isolated from human plasma (38), and by its biologic activity, which was characteristic of PAF (33) . The specific activity of [3H-acetyl]PAF varies little regardless of the vessel of origin of the EC or the agonist used (33) .
The measurement of [3H-acetyl]PAF synthesis in HUVEC was performed as described (22) , and was similar to the method just outlined for BPAEC. Measurement ofCa2" uptake and release by EC Assays in divalent cation-free buffer. Incubations of EC with tritiated acetate and H202 were done in nominally Ca2' and Mg2e-free HBSS with Hepes and 0.1% EDTA, or in control HBSS with Hepes. Assay of 4"Ca21 flux into endothelial cells. Culture medium was removed from confluent monolayers of EC and the monolayers washed twice with 1 ml of HBSS. The monolayers were then incubated at 250C for the indicated times with 1 ml of HBSS ([Ca2+] = 1.3 mM, pH 7.4) containing 5 qCi/ml of 45CaC12 and the indicated concentra-tions ofagonist. Control dishes were incubated identically, but without an agonist. At the indicated times, the incubation buffer was removed and the culture dish immersed in three sequential washes of ice-cold HBSS (without calcium) containing 0.1% EDTA to remove any remaining extracellular 45Ca2+. The monolayers were solubilized in 1 ml of 1 M NH40H and placed in scintillation vials for determination of radioactivity.
Assay of45Ca2fluxfrom EC. Culture medium was removed from EC monolayers and replaced with 1 ml of medium M 199 containing 5 ,UCi/ml of 45CaC12. After 1 h of incubation at 370C, the labeling medium was removed and the monolayers were washed twice with 1 ml of HBSS. The monolayers were stimulated with the indicated agonist concentration in 1 ml of calcium-free HBSS (pH 7.4) at 250C. Control incubations were performed identically, but without an agonist. At the indicated times, the incubation buffer was removed and the monolayers were washed with 1 ml of HBSS. The monolayers were solubilized in 1 ml of 1 M NH40H and placed in scintillation vials for determination of radioactivity.
Measurements ofEC injury and cytotoxicity
The morphology of EC and detachment of EC from the monolayers was assessed by phase-contrast microscopy. The uptake of trypan blue was measured by a minor modification of the method detailed by Patterson (39) . Lactate dehydrogenase (LDH) release was measured as described (36) .
Measurement ofneutrophil adherence to EC and to cell-free surfaces Human neutrophils were isolated, labeled with I"'indium, and their adherence to HUVEC monolayers was measured as described (40, 41) . In most experiments EC monolayers were pretreated with H202 (diluted from a 30% stock solution with HBSS/0.5% human serum albumin) for various times at 370C in an atmosphere of 5% C02, 95% air. In some experiments HUVEC were pretreated with H202 in Ca2+and Mg2+-free HBSS with 0.5% human serum albumin or in Ca2+and Mg2+-free HBSS with 0.5% human serum albumin, 20 mM Hepes, and I mM EGTA (pH 7.2-7.4) instead of control HBSS. Radiolabeled PMN were then added and incubated as indicated in Fig. 8 . Calculation of the fraction of adherent PMN was done as described (40). In some experiments H202 or another agonist was added to suspensions of "''In-labeled PMN overlying EC monolayers and adherence was determined after incubation at 37°C in 5% C02, 95% air ("coincubation" experiments, Table II ). Measurement of the adherence of "'In-labeled PMN to cell-free surfaces was done by a minor modification of the method of Zimmerman et al. (42) . The cell-free surfaces included tissue culture wells pretreated for 1 h at 37°C with 50 or 2000 ug/ml gelatin (Type A, Fischer Scientific Co.), 50 gg/ml human fibronectin (Collaborative Research, Inc., Waltham, MA) or whole human serum. Subendothelial matrices were prepared as described (42) .
Results
H202 stimulates BPAEC to synthesize PAF. In a preliminary experiment, we found that [3H-acetyl]PAF accumulation by HUVEC that were prelabeled with [3H]acetate and then incubated with PMN and ionophore A23187 (IoA, 10 ,uM) for 5 min was greater than when incubated with IoA alone, suggesting the possibility that IoA-stimulated PMN released an activity that enhanced PAF synthesis (EC + IoA, 1,250+500 cpm; PMN + IoA, 310±125 cpm; EC + PMN + IoA, 6,400±700 cpm; buffer-treated EC, PMN, or EC + PMN, 100+30 cpm or less). In three subsequent experiments, we found that there was increased accumulation of [3H-acetyl]PAF when EC were in-cubated in the presence of PMA-treated neutrophils (twoto fivefold increase over control, depending on time of incubation, ratio of PMN to EC, and concentrations of phorbol myristate acetate [PMA]). Since PMA did not stimulate PAF synthesis in EC or PMNs when incubated alone under these conditions, this result also suggests that a product of the activated PMN induced PAF synthesis. While the specific molecular specie(s) involved was not identified in these experiments, and conditions that might indicate its nature by inference were not included (i.e., the presence of 02 radical "scavengers" such as catalase, protease inhibitors, etc.), we considered the possibility that the activity was H202. H202 is generated by neutrophils activated by IoA or PMA, and can alter membrane phospholipids in EC (7, 43) . To determine if H202 can stimulate PAF synthesis in endothelium, we first examined its effect on bovine endothelial cells and found that cultured BPAEC reproducibly synthesized PAF when they were treated with H202. In 20 experiments, EC treated with 10 mM H202 for 30 min incorporated 8,948±5,089 cpm of [3H]acetate into [3Hacetyl]PAF, compared with 386±221 cpm in buffer-treated EC. The response was dependent on the concentration of H202 and demonstrated a narrow concentration-response relationship. There was consistent accumulation of [3H-acetylJ-PAF at concentrations of H202 of 1-20 mM with a maximal effect at 8-10 mM ( Fig. 1 ). At concentrations of H202 above 10 mM, there was a concentration-dependent decrease in incorporation of labeled acetate (Fig. 1 ). In three experiments there were 1,033±513 cpm in [3H-acetyl]PAF in BPAEC treated with 100 mM H202 compared with 10,333±3,177 cpm in EC stimulated with 10 mM H202. There was no incorporation of [3H]acetate in BPAEC treated with 500 or 1,000 mM H202 (n = 2). The accumulation of [3H-acetyl]PAF in H202- C- for these periods.
To establish that H202 was the stimulus responsible for PAF synthesis, catalase was added to incubation solutions containing H202. We found that PAF synthesis by BPAEC was inhibited by -90% by coincubation with catalase ( Fig. 1 , see legend; Table I ). Inactivation of catalase by boiling prevented the inhibition (Table I) . Furthermore, superoxide dismutase was largely ineffective in preventing H202-stimulated PAF synthesis (Table I) . Incubation of BPAEC for 30 min in buffer containing glucose (22 mM) and glucose-oxidase (1,600 mU/ml), a system that generates H202 (5, 8, 12) , caused the accumulation of 4,800+400 cpm [3H-acetyl]PAF in the absence of catalase and 32±10 cpm when catalase was present (duplicate determinations). Glucose/glucose oxidase also stimulated PAF accumulation in BPAEC in three additional experiments in which the concentration of glucose oxidase was varied between 100 and 1,600 mU/ml. In two experiments treatment of BPAEC with bleomycin (IO-' U/ml), a drug that may cause pulmonary vascular injury in part by the generation of oxygen radicals (2), or BCNU (1,3bis[chloroethyl]-nitrosourea; 50 mg/ml), which may enhance H202-induced EC injury by disrupting the glutathione redox cycle (8) , caused a two-to fivefold potentiation of PAF accumulation in response to 10 mM H202. Neither drug potentiated PAF accumulation stimulated by bradykinin (33) in parallel incubations.
H202, and H202-generating systems, have previously been reported to stimulate EC to synthesize PGI2 (43), and we have found that the synthesis of PGI2 and PAF are concordant events in activated human and bovine endothelium (22, 23) .
In an experiment to test this association with H202 as the To determine if H202 also induces calcium transfer, we stimulated BPAEC monolayers in buffer containing 45Ca2+ and found a time-dependent increase in labeled calcium associated with the cells (Fig. 3 A) . Ionophore A23 187 (IoA) also stimulated 45Ca21 uptake in parallel incubations. A second experiment yielded qualitatively similar results. To further demonstrate that H202 increased the permeability of EC plasma membranes to Ca2", we preloaded the cells with "5Ca2" and then treated them with H202 or IoA in calcium-free Bovine pulmonary artery endothelial cells (106 cells per dish) were incubated at 25°C in the presence of 45Ca2+ (5 ACi/ml) in HBSS containing control buffer, H202 (10 mM), or calcium ionophore A23187 (10-5 M). At the indicated times, the incubation buffer was removed and the cellular 45Ca2+ content determined as described in Methods. Each point represents a single determination in one dish. The results shown are representative of two separate experiments. (B) H202stimulated 45Ca2' efflux from preloaded BPAEC. Bovine pulmonary artery cells were incubated in medium containing 5 ,uCi/ml 45Ca2+ for 1 h at 37°C. The incubation medium was removed, the monolayers were washed with HBSS, and were then incubated at 25°C in calcium-free control buffer (HBSS, pH 7.4) or the same buffer containing H202 (10 mM) or calcium ionophore A23187 (10-' M). At the indicated times, the incubation buffer was removed and the 45Ca2+ content was determined as described in Methods.
buffer. This maneuver created a large concentration gradient between Ca2" in the cytoplasm and the extracellular space;
under these conditions increased plasma membrane permeability to calcium would result in efflux of Ca2" from the cell.
Stimulation of the EC with 10 mM H202 resulted in loss of labeled Ca2+ from the cells, as did treatment with the ionophore ( Fig. 3 B) . These experiments demonstrate that H202 induces increased permeability of EC membranes for Ca2+ and/or that it activates calcium transport mechanisms that cause both uptake and extrusion. The alterations in Ca2+ transport were temporally associated with PAF synthesis (Fig. 2 ).
H2Orinduced PAF synthesis by BPAEC is temporally dissociatedfrom lytic cell injury. BPAEC, when subjected to concentrations of H202 that induced maximal synthesis of PAF (Fig. 1 ), exhibited no morphologic evidence of injury such as swelling, detachment from the monolayer, or lysis. Moreover, trypan blue was excluded by EC stimulated with H202 in this concentration range (Fig. 4 ). This finding indicates that the synthesis of PAF is not simply a consequence of plasma membrane disruption, and that the increased permeability to Ca2+ (previous section) was selective rather than nonspecific. There was a parallel increase in abnormal cell morphology and trypan blue uptake above H202 concentrations of 20 mM, accompanying the dramatic fall in PAF accumulation at these concentrations (Fig. 4) . A time course of PAF accumulation compared to trypan blue uptake in response to 10 mM H202 demonstrated that there was minimal uptake of the dye at the time of maximal PAF accumulation, followed by a progressive increase in trypan blue uptake during the descending slope of the PAF accumulation curve (Fig. 5 ). with a variety of agonists that interact with plasma membrane receptors. However, it is possible that it may be released from EC that are injured by oxidants or other pathologic stimuli (44) . To determine if PAF synthesized by H202-stimulated BPAEC is released into the fluid phase, we incubated EC monolayers with H202 for various periods and measured the fractions of [3H-acetyl]PAF in the incubation buffer and in the cells after they were extracted separately. In four experiments, 1% or less of the labeled PAF was found in the incubation medium after stimulation of the EC with 10 mM H202 for 30 min at 370C. We found a similar result when 30 mg/ml fatty acid-free bovine serum albumin, to which PAF binds, was included in the incubation buffer. In an experiment to examine the time dependency of the distribution of newly synthesized PAF in H202-stimulated BPAEC, the phospholipid re- I. 20 20 40 60 TIME (MINUTES) Figure 5 . The time-dependent alterations in PAF accumulation and trypan blue uptake are dissociated in H202-stimulated BPAEC. [3Hacetyl]PAF accumulation and trypan blue uptake were measured as described in Fig. 4 in replicate BPAEC monolayers that were stimulated with 10 mM H202.
mained associated with the cell pellet at all time points and little, if any, was released into the incubation medium ( Fig. 6 ). Even at 60 min, when as many as 40% of the EC treated with 10 mM H202 may be permeable to trypan blue (mol wt 961) ( Fig. 5 ), PAF (mol wt = 524) was retained by the endothelium.
H202 stimulates PAF synthesis by human endothelium.
HUVEC were used as a readily available human cell type that shares many common features with in situ endothelium and with endothelium cultured from other human vessels (19) . We found that H202 reproducibly stimulated [3H]acetate incorporation into [3H-acetyl]PAF in these cells. The response was concentration-dependent with a threshold at 0.5-1 mM H202, a maximal effect at 5-10 mM H202, and a sharp decrease at 100 mM H202. In contrast, H202 (1-100 mM) did not stimulate [3H-acetyl]PAF accumulation in isolated human PMN, even though PMN synthesize PAF in response to several agonists (36) , indicating a degree of specificity of the H202 effect. PAF accumulation by H202-stimulated HUVEC was also time-dependent. In each of five experiments maximal [3H-acetyl]PAF occurred at 10-20 min in response to 10 mM H202, followed by a variable decline to basal, or near basal, levels by 60 min (Fig. 7) . Thus the accumulation of PAF in HUVEC stimulated with a maximal concentration of H202 was usually more abbreviated than in BPAEC (Figs. 2, 5, and 6). In an experiment comparing submaximal and maximal concentrations of H202 (1 and 10 mM) in HUVEC, there was a broader and more prolonged time course in response to the lower concentration of H202 (Fig. 7 ). HUVEC treated with 10 mM H202 excluded trypan blue during the first 60 min of incubation, the period of PAF accumulation, and the monolayers remained intact. The response thereafter was variable. In one experiment essentially all cells were permeable to trypan blue, and there was extensive detachment and lysis of the EC, by 120 min. In two additional experiments EC developed altered morphology (retracted, angular cells) after 2 h, but significant desquamation of EC and trypan blue uptake did not occur until 3-6 h after treatment of the EC with H202. In addition, in two experiments EC were treated with 10 mM H202 for 20 min, incubated with catalase (500 U/ml, to degrade any remaining extracellular H202) or control buffer for 10 min, and then covered with complete culture medium and returned to the incubator for 18 h. In both experiments there was an adherent monolayer of EC that excluded trypan blue at the end of this period, although individual cells had been lost from the monolayer and many cells had undergone shape change; there was no obvious difference in monolayers "rescued" with catalase and complete medium compared to complete medium alone. These experiments indicated that PAF synthesis was temporally dissociated from lethal injury to the EC assessed by trypan blue uptake and from complete morphologic disruption of the monolayer. Significant LDH release was a late event that was also dissociated from PAF synthesis. 8% and 12% of total cellular LDH was released from HUVEC treated with 1 mM or 10 mM H202 for 60 min (Fig. 7) . In a second experiment there was no LDH release and maximal PAF accumulation when HUVEC monolayers were stimulated with 10 mM H202 for 10 min, whereas there was decreased PAF accumulation in association with increased LDH release in response to 100 and 500 mM H202 (90% LDH release from EC treated with 500 mM H202). Thus in HUVEC, as in BPAEC, PAF synthesis was temporally dissociated from indices of extensive plasma membrane damage and cytolytic injury. Also as in H202-stimulated BPAEC, the newly synthesized [3H-acetyl]PAF was retained by the EC (not shown).
In an experiment to determine the effect of pretreatment of EC with H202 on subsequent PAF synthesis stimulated by receptor-mediated agonists, we pretreated HUVEC with 0.5 or 3 mM H202 for 10 min, removed the buffer, and added human a-thrombin (2.0 U/ml) (20, 42) for an additional 10-min incubation. Pretreatment with 0.5 or 3 mM H202 reduced PAF accumulation by 47% and 5 1 %, respectively, compared to the thrombin response in replicate monolayers pretreated with control buffer. H202 induces endothelial cell-dependent neutrophil adhesion. We have previously observed that the synthesis of PAF by HUVEC is tightly coupled with a functional alteration that results in the adhesion of neutrophils (PMN) to the EC (20, (40) (41) (42) , suggesting that the two events are related and that they are components of a rapid EC activation response (23) . To determine if H202 induces endothelial cell-dependent neutrophil adhesion, we pretreated HUVEC monolayers for 20 min with H202 (10 mM); the H202 was then removed and replaced with buffer containing "'In-labeled PMN. Neutrophil adhesion was measured after a 5-min incubation. In eight experiments, this resulted in a two-to sixfold increase in the adhesion of labeled PMN when compared to adherence to EC pretreated with control buffer (Table II) . Examination of the monolayers by phase-contrast microscopy demonstrated that single neutrophils adhered to the surface of the EC, with rare aggregates of PMN also adhering, and that the monolayers were intact at this time. The response was concentration-dependent ( Fig. 8) with a threshold at 0.5-1.0 mM H202 and a maximal effect at 5-10 mM H202. Pretreatment of HUVEC with 100 mM H202 resulted in PMN adherence that was con- In pretreatment protocols, EC monolayers were incubated with control buffer (HBSS/0.5% human serum albumin) or H202 in HBSS/0.5% human serum albumin for 20 min at 37°C; the incubation mixture was then removed, "'In-labeled PMNs were added and incubated for 5 min, and adherence determined as in Methods and Fig. 8 . In some experiments EC were washed with 1 or 2 vol of HBSS/0.5% human serum albumin after incubation with H202, before addition of PMN; in other experiments catalase (500 U/ml) or SOD (500 U/ml) was included in the incubation mixture with H202. In experiments with cell-free surfaces (CFS), "I'In-labeled PMN were added to gelatin-coated culture wells, buffer or H202 was added, and PMN adherence was measured after 5 min of incubation. In coincubation protocols, control buffer or H202 was added to "'In-labeled PMN overlying EC monolayers and PMN adherence was determined after a 20-min incubation. Figure 8 . Endothelial cell-dependent PMN adherence is induced by H202 in a concentration-dependent fashion. HUVEC were pretreated with control buffer (HBSS/0.5% human serum albumin) or with various concentrations of H202 diluted in HBSS/0.5% human serum albumin for 20 min at 37°C. Catalase (500 U/ml) was included in some incubations. The incubation mixtures were then removed and "'.In-labeled PMNs (5.5 X 106/ml in HBSS/0.5% human serum albumin) were added and incubated for an additional 5 min. The fraction of adherent PMNs was determined as described (40) after confirming that the leukocytes had adhered to the surface of the EC by inspection (phase-contrast microscopy). The means of results from two experiments are shown. siderably lower than adhesion induced by 10 mM H202 (12% vs. 25%, n = 5 and 8, respectively), a pattern similar to that seen when PAF accumulation was assayed. H202-induced PMN adhesion was inhibited by catalase ( Fig. 8 ; Table II) but not by SOD (Table II) . Incubation ofEC with H202 in divalent cation-free buffer completely inhibited subsequent PMN adhesion; addition of Ca2+, but not Mg2+, returned the response to control levels. Direct addition of 10 mM H202 to PMN suspensions overlying HUVEC monolayers, followed by a 20min incubation, also stimulated PMN adhesion, but the adherence under these conditions was less than in parallel incubations where EC were pretreated with H202 for 20 min before addition of the PMN (Table II) . This may be in part due to the generation of PGI2, which can blunt PMN adhesiveness (45), by the H202-stimulated EC, or to the ability of PMN to "scavenge" H202 (46) . Washing of the EC monolayers with buffer after pretreatment with H202 did not diminish PMN adhesion when the leukocytes were subsequently added and incubated for 5 min (Table II ). In addition, H202 did not cause PMN to adhere to cell-free surfaces (gelatin-coated tissue culture wells) when it was added to the PMN and they were incubated for the same period as in incubations with EC (Table II) ; this excludes the possibility that "carryover" of H202 directly induced increased PMN adhesiveness. Pretreatment of subendothelial matrices or incubation wells coated with gelatin (50 mg/ml), Fn (50 mg/ml), or whole human serum (used as a source of vitronectin and thrombospondin as well as vWF and Fn) with 10 mM H202 for 20 min followed by the addition of PMN for 5 min did not cause increased PMN adhesion compared to surfaces pretreated with control buffer (n = 2). Thus, under the conditions of these experiments, the H202-stimulated PMN adhesion resulted from increased adhesiveness of the endothelium and was dependent on the EC. The H202-induced neutrophil adhesion was a time-dependent event. Pretreatment ofthe HUVEC with 10 mM H202 for as little as 5 min resulted in enhanced leukocyte binding. Although there was variation from experiment to experiment, the maximal effect was at 20 min and PMN adhesion declined when the monolayers were pretreated for longer periods. This temporal pattern was similar to the time course of H202-stimulated PAF accumulation in HUVEC. Therefore, we measured PAF accumulation and neutrophil adhesion in parallel using replicate EC monolayers from the same culture. The two responses were concordant in these experiments ( Fig. 9 ).
Pretreatment of HUVEC with the potent phospholipase inhibitor p-bromophenacyl bromide (pBPB; 25 ,uM for 15 min) (47) completely prevented enhanced PMN adhesion to H202-treated monolayers, reducing the adherence to the level seen in monolayers treated with control buffer rather than H202. PMN adhesion induced by thrombin, but not adhesion stimulated by N-formyl-methionyl-leucyl-phenylalanine (fMLP), was blocked by pBPB in parallel incubations. In two experiments PAF synthesis by HUVEC stimulated with H202 (5 or 10 mM), thrombin, or IoA was inhibited by greater than 95% by pretreatment ofthe EC with pBPB (25 ,m) for 15 min.
In two experiments to determine if RNA or protein synthesis was required for H202-induced PMN adhesion, pretreatment of HUVEC with cycloheximide (20 or 35 ,uM for 1 or 4 h) (48) or actinomycin D (5 ,ug/ml for 4 h) (49) caused no decrease in neutrophil adherence to EC monolayers treated with 5 or 10 mM H202. Inclusion of monensin (1 ,uM) (48) during the 20-min preincubation period of HUVEC with 10 mM H202 did not reduce PMN adhesion to the monolayers in two experiments, suggesting that redistribution of preformed pro- Figure 9 . Endothelial cell-dependent PMN adhesion and PAF synthesis are temporally-associated events in H202-stimulated EC. HUVEC were grown in individual 35-mm culture dishes, and incubated with 10 mM H202 for the indicated times. [3H-acetyl]PAF accumulation was determined as in Methods and PMN adhesion was measured as in Methods and Fig. 8 . The figure indicates the mean data from three experiments for each measurement; in two experiments [3H-acetyl]PAF accumulation and PMN adhesion were measured in parallel in replicates from the same EC culture. teins was not involved (50) . Furthermore, polyclonal antisera to human vWF and FN did not block PMN adhesion to H202-treated EC (n = 2). These results suggest that rapid expression of these adhesive glycoproteins on the EC surface (51), or alteration by H202 of vWF or FN that was constitutively associated with the EC plasma membrane or pericellular matrix (52), was not the mechanism of enhanced PMN adhesion. In an additional experiment we pretreated PMNs with buffer, 10-8 M PAF, or 10-8 M lyso-PAF (which is biologically inactive [24] ) for 5 min at 370C, added them to EC monolayers that had been pretreated with 5 mM H202 for 20 min, and then measured adherence after a 5-min incubation. Pretreatment with PAF reduced PMN adhesion to H202-activated monolayers by 65%, compared to 13% with lyso-PAF. Adherence of PMN induced by exogenous fMLP was not substantially reduced by either PAF or lyso-PAF (88% of the value for buffer-pretreated PMN in each case). These data are consistent with specific desensitization ofPMN adhesion to H202-treated endothelium by pretreatment with PAF (40, 41) .
Discussion
In this report we present evidence that BPAEC and HUVEC in primary culture synthesize and accumulate PAF when they are stimulated with hydrogen peroxide. Accumulation of PAF induced by H202 is concentrationand time-dependent, is associated with a calcium flux across the plasma membrane, and is temporally dissociated from lytic cell injury. H202 also induces rapid endothelial cell-dependent adherence ofneutrophils that is temporally coupled with PAF accumulation in human endothelium. These observations document that H202 can directly activate EC and suggest a new mechanism by which oxidants may initiate or amplify inflammatory vascular injury. Although the concentrations of exogenously delivered reagent H202 required to induce these effects were high, and it is unknown if such concentrations are achieved in inflammed tissue in vivo, neutrophils generate and release sufficient H202 to cause high local concentrations (1, 12, 53) 2 and high local concentrations ofendogenously generated oxidants may occur under hyperoxic conditions (3) . Furthermore, the experiments that we have described may indicate a paradigm for responses of EC that are perturbed by oxidants, regardless of whether or not the concentrations of H202 that we utilized are achieved in vivo.
It has been documented previously that active oxygen species, including H202, can cause cytotoxic injury to EC (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . H202 causes lysis of cultured endothelium (4) (5) (6) (7) (8) (9) (10) (11) 56) and, in concert with proteases generated by inflammatory cells (57) , may cause desquamation of EC from the subcellular matrix.
Similar alterations in vivo would result in wholesale destruction of the luminal surface. However, evidence for widespread EC lysis and extensive denudation of the intima is not commonly found in the acute phases ofconditions that are thought to involve oxidant-induced vascular injury, even though there is concurrent evidence for abnormal vascular function (such as increased permeability, altered vasoreactivity, or thrombosis) 2 . Recently Nathan (54) has reported that PMN release "massive" quantities of H202 under certain conditions. Also, Bozeman et al. (55) estimated that millimolar concentrations of H202 may be achieved in inflammatory lesions containing neutrophils. (2, 3, 58, 59) . This suggests that the EC are intact, but that their basal functions have been perturbed. Furthermore, some models of oxidant-induced vascular injury indicate that there are reversible alterations in endothelial permeability that do not involve cell death (14) . The biochemical mechanisms involved in oxidant-induced, nonlytic EC alterations are largely unknown (1) . Our studies demonstrate that H202 induces PAF synthesis by human and bovine endothelium, a biochemical response that may contribute to such functional alterations.
PAF synthesis requires specific enzymatic activities (60) . Although more than one pathway for PAF synthesis exists in mammalian cells, in endothelium it occurs by the sequential phospholipase A2-catalyzed hydrolysis of 1-0-alkyl-2-acyl-snglycero-3-phosphocholine to form 1-0-alkyl-sn-glycero-3phosphocholine ("lyso-PAF') followed by acetylation of this molecule to form PAF (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine); the latter step is catalyzed by an intracellular acetyl transferase (60) (61) (62) . The mechanism by which H202 "switches on" this enzymatic pathway may involve a Ca2' flux across the EC plasma membrane since H202 caused increased permeability of the EC for Ca2" and accumulation of radiolabeled Ca2 in the cells (Fig. 3 ). Furthermore, a sustained increase in intracellular Ca2`induced by receptor-mediated and receptor-independent perturbation of EC results in PAF synthesis (Whatley et al., manuscript submitted for publication). Shasby et al. previously reported that a xanthine/xanthine oxidase system caused increased permeability of porcine EC for 45Ca2' (63) ; preliminary experiments indicate that linoleate peroxide causes 45Ca2+ release from preloaded, cultured EC and that H202 induces the generation of linoleate peroxide by these cells (64) . Lipid peroxides, including linoleate peroxide, may act as Ca2+ ionophores (65). Thus H202 may have induced increased calcium permeability and PAF synthesis by the EC by causing the generation of lipid peroxides. Increased intracellular Ca2+ also initiates the synthesis of PGI2 by endothelium (66) . Consistent with this, we found that H202 induced the coordinate accumulation of PAF and 6-keto-PGF,a (see Results) confirming earlier observations that H202 can stimulate PGI2 synthesis by EC (7, 43) as well as our previous finding that PAF and PGI2 synthesis are initiated in concert in activated endothelium (22, 23, 33) . These findings suggest that H202 induces Ca2+ flux, activation of phospholipase A2 (thought to be a Ca2+-dependent enzyme), and the hydrolysis of one or more membrane phospholipid precursors in endothelium, yielding free arachidonate and lyso-PAF for subsequent conversion to PGI2 and PAF, respectively (Whatley et al., manuscript submitted for publication).
As in our experiments, previous studies with cultured EC from several sources demonstrate that enzymatic synthesis of biologically active molecules can be stimulated by H202 in the absence of lytic injury (7, 43) . Additional biologic and biochemical alterations in EC induced by H202 or other active 02 species at time points before cell lysis, or in cells treated with sublytic concentrations of H202, include potassium efflux and the release of cytoplasmic purines (7) , reorganization of actin filaments (63) , and reduction in cellular ATP levels (11). We found that the concentration-response relationship for H202-induced PAF synthesis was quite narrow (Fig. 1) , and that concentrations of H202 greater than 10 mM decreased or abolished PAF accumulation in both BPAEC and HUVEC.
These results suggest that high concentrations of H202 may inactivate one or more of the enzymes involved in PAF syn-thesis. We also found that pretreatment of HUVEC with submaximal concentrations of H202 reduced PAF accumulation when the monolayers were subsequently stimulated with thrombin (see Results). A variable effect of oxidants on eicosanoid synthesis, depending on the concentration of the oxidant, has also been reported (7, 10, 43) . Whorton et al. (10) observed that pretreatment of cultured porcine endothelium with concentrations of H202 (0.01-0.1 mM) that did not induce PGI2 synthesis, or coincident cell lysis, impaired PGI2 synthesis when the EC were subsequently treated with exogenous arachidonate or ionophore A23187, and that cyclooxygenase, but not PGI2 synthase, was inhibited under these conditions. Taylor et al. found that t-butyl hydroperoxide stimulated the production of PGI2 at low concentrations and inhibited it at high concentrations; the inhibition at high concentrations was reversed by addition ofan oxygen radical scavenger (67) . These reports, and our observations on PAF synthesis, are consistent with evidence that H202 and other oxidants can cause rapid, selective damage to enzymes and other intracellular proteins, and intracellular proteolysis of the altered molecules (68) . Thus the effect of H202 on the production of lipid autacoids by EC may depend heavily on variables that include the concentrations of the oxidant (Figs. 1 and 7) and endogenous antioxidants (8, 12) , time (Fig. 7) , and the presence or absence of additional agonists.
We found that H202 induced neutrophil adherence that was dependent on the endothelium. Endothelial cell-dependent PMN adherence is a novel biologic response to H202 that has not been previously reported, although PMN adhesion to the intima of oxidant-injured vessels and to EC cultured under hyperoxic conditions has been described (69, 70) . EC-dependent PMN adherence has been observed when cultured endothelium is stimulated by a variety of naturally occurring inflammatory mediators including thrombin (20, 40, 42) , sulfidopeptide leukotrienes (41) , and cytokines (49, 71) , and may contribute to the accumulation of PMN in vessels in certain pathologic conditions such as the adult respiratory distress syndrome (72) . In our experiments, H202-induced, EC-dependent neutrophil adherence was very rapid, with an onset within minutes and a peak that usually occurred within 20 min ( Fig. 9) , and was not dependent on de novo protein synthesis by the EC. These features clearly differentiate it from EC-dependent PMN adhesion stimulated by the cytokines tumor necrosis factor and interleukin 1, and by endotoxin, which require -1 h for onset, 4-6 h for the maximal effect, and the synthesis of new protein(s) (49, 71) . The rapidity with which H202 stimulates EC-dependent PMN adhesion is similar to the onset induced by thrombin, LTC4 and LTD4 (20, (40) (41) (42) .
There are several possible molecular events that may contribute to H202-induced EC-dependent adhesion. H202 may stimulate the translocation of a preformed adhesive protein from an intracellular compartment to the EC plasma membrane. The lack of an effect of 4-h preincubation of the EC with cycloheximide, or of treatment of EC with monensin (50), argue against this possibility, and polyclonal antibodies against two adhesive glycoproteins (vWF and fibronectin) that are associated with EC (51) did not inhibit PMN adhesion. A second possibility is that H202 induces a conformational change, or a change in the primary structure, of a constitutive surface or pericellular protein (68) causing it to become adhesive (52) . However, treatment of matrices of relevant proteins or subendothelial matrices with H202 under the conditions of these experiments did not induce enhanced PMN adherence. A third possibility is that PAF that is synthesized by H202stimulated EC mediates the adhesive interaction. We have previously reported evidence that PAF that is endogenously synthesized by activated EC, and that remains cell-associated, may cause PMN adhesion (23, (40) (41) (42) 61) . In the current experiments the time courses for H202-stimulated PAF accumulation and for PMN adhesion to the EC were strikingly similar ( Fig. 9 ) as were the concentration-response relationships. H202-induced PMN adhesion was inhibited by the potent (47, 73) but nonspecific (73) phospholipase inhibitor pI3PB, which also inhibited PAF synthesis. Furthermore, there was reduced binding of PMN that were specifically "desensitized" by pretreatment with submaximal concentrations of PAF to H202treated EC. These observations suggest that a portion of the PAF synthesized by EC in response to H202 is located in the plasma membrane or is otherwise available for interaction with adjacent neutrophils. In addition, competitive PAF receptor antagonists diminish PMN adherence to H202-treated HUVEC (Zimmerman et al., manuscript in preparation).
PAF synthesis, EC-dependent PMN adhesion, and PGI2 production are rapid responses of endothelial cells that are activated by specific agonists (23) . This report demonstrates that H202, like receptor-mediated agonists, can stimulate the first two ofthese, adding them to the repertoire ofbiochemical and biologic responses of vessels that are perturbed by active 02 metabolites (1) . Because of the vasoactive and prothrombotic effects of PAF (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) 44) , and the ability of adherent PMNs to cause endothelial damage (1, 4-6, 56, 57) , activation of EC by H202 has the potential to mediate pathologic events in oxidant-induced vascular injury states before the onset of lytic destruction of the intima, or in segments of the intima that are not destined for necrosis because they have been perturbed by sublytic concentrations of the toxic 02 species. Since PMN release H202 into the fluid phase (1, 55) , the activation of EC by H202, resulting in PAF synthesis, provides the basis for a reciprocal amplification loop between the two cells. We have observed that PMN that become adherent to activated EC develop morphologic evidence indicating that the leukocytes in turn become activated (membrane spreading and polarization), suggesting that signals received by the PMN from the EC can close such an amplification loop (40-42, 61) . It is also possible that such a reciprocal interaction may occur in physiologic as well as pathologic inflammatory events, since the EC generate biologically active molecules (74), such as PGI2, that may modulate PMN responses (45, 74, 75), and create a regulated, homeostatic interaction.
